JP2012514020A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012514020A5 JP2012514020A5 JP2011544017A JP2011544017A JP2012514020A5 JP 2012514020 A5 JP2012514020 A5 JP 2012514020A5 JP 2011544017 A JP2011544017 A JP 2011544017A JP 2011544017 A JP2011544017 A JP 2011544017A JP 2012514020 A5 JP2012514020 A5 JP 2012514020A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- quinazolin
- ylamino
- chloro
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08360043.7 | 2008-12-29 | ||
| EP08360043 | 2008-12-29 | ||
| PCT/EP2009/067494 WO2010076238A1 (en) | 2008-12-29 | 2009-12-18 | Substituted quinazoline compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012514020A JP2012514020A (ja) | 2012-06-21 |
| JP2012514020A5 true JP2012514020A5 (https=) | 2013-03-28 |
Family
ID=41735344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011544017A Pending JP2012514020A (ja) | 2008-12-29 | 2009-12-18 | 置換キナゾリン化合物 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8389530B2 (https=) |
| EP (1) | EP2381943A1 (https=) |
| JP (1) | JP2012514020A (https=) |
| KR (1) | KR20110120878A (https=) |
| CN (1) | CN102333533A (https=) |
| AU (1) | AU2009334869A1 (https=) |
| BR (1) | BRPI0924067A2 (https=) |
| CA (1) | CA2748319A1 (https=) |
| CO (1) | CO6390105A2 (https=) |
| CR (1) | CR20110368A (https=) |
| DO (1) | DOP2011000209A (https=) |
| EA (1) | EA019110B1 (https=) |
| EC (1) | ECSP11011204A (https=) |
| IL (1) | IL213742A0 (https=) |
| MA (1) | MA32968B1 (https=) |
| MX (1) | MX2011007064A (https=) |
| NI (1) | NI201100134A (https=) |
| NZ (1) | NZ593949A (https=) |
| PE (1) | PE20120424A1 (https=) |
| SG (1) | SG172415A1 (https=) |
| TN (1) | TN2011000319A1 (https=) |
| WO (1) | WO2010076238A1 (https=) |
| ZA (1) | ZA201104777B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR081960A1 (es) | 2010-06-22 | 2012-10-31 | Fovea Pharmaceuticals Sa | Compuestos heterociclicos, su preparacion y su aplicacion terapeutica |
| SMT202100451T1 (it) | 2012-07-11 | 2021-09-14 | Blueprint Medicines Corp | Inibitori del recettore di crescita dei fibroblasti |
| CA2928042C (en) | 2013-10-25 | 2022-05-10 | Blueprint Medicines Corporation | Inhibitors of the fibroblast growth factor receptor |
| WO2015108992A1 (en) | 2014-01-15 | 2015-07-23 | Blueprint Medicines Corporation | Heterobicyclic compounds and their use as fgfr4 receptor inhibitors |
| KR101715448B1 (ko) * | 2014-07-16 | 2017-03-20 | 주식회사 큐리언트 | 염증성 질환 치료용 화합물 |
| TWI699355B (zh) | 2014-12-24 | 2020-07-21 | 美商基利科學股份有限公司 | 喹唑啉化合物 |
| BR112017013440A2 (pt) | 2014-12-24 | 2018-01-09 | Gilead Sciences, Inc. | compostos de isoquinolina para o tratamento de hiv |
| ES2735087T3 (es) | 2014-12-24 | 2019-12-16 | Gilead Sciences Inc | Compuestos de pirimidina fusionados para el tratamiento de VIH |
| CN112239459B (zh) * | 2019-07-19 | 2021-11-26 | 中国科学院上海药物研究所 | 稠环嘧啶氨基化合物、其制备方法、药物组合物及应用 |
| CN115916759B (zh) * | 2020-06-19 | 2025-07-15 | 泰州红云制药有限公司 | 取代喹唑啉类化合物、其制备方法、药物组合及应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2386955A1 (en) * | 1999-11-22 | 2001-05-31 | Warner-Lambert Company | Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| EP1590341B1 (en) | 2003-01-17 | 2009-06-17 | Warner-Lambert Company LLC | 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation |
| CN1882345A (zh) | 2003-10-16 | 2006-12-20 | 希龙公司 | 作为raf激酶抑制剂以治疗癌症的2,6－二取代的喹唑啉、喹喔啉、喹啉和异喹啉 |
| KR20070011458A (ko) | 2004-04-08 | 2007-01-24 | 탈자진 인코포레이티드 | 키나제의 벤조트리아진 억제제 |
| PL382308A1 (pl) | 2004-08-25 | 2007-08-20 | Targegen, Inc. | Związki heterocykliczne i sposoby stosowania |
| US20070054916A1 (en) | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| US20060247250A1 (en) | 2005-03-16 | 2006-11-02 | Targegen, Inc. | Pyrimidine inhibitors of kinases |
| JP5079500B2 (ja) * | 2005-04-28 | 2012-11-21 | 協和発酵キリン株式会社 | ２−アミノキナゾリン誘導体 |
| NZ563984A (en) | 2005-06-08 | 2011-11-25 | Targegen Inc | Methods and compositions for the treatment of ocular disorders |
| TW200808739A (en) * | 2006-04-06 | 2008-02-16 | Novartis Vaccines & Diagnostic | Quinazolines for PDK1 inhibition |
| CA2673003A1 (en) * | 2006-12-22 | 2008-07-03 | Novartis Ag | Quinazolines for pdk1 inhibition |
-
2009
- 2009-12-18 AU AU2009334869A patent/AU2009334869A1/en not_active Abandoned
- 2009-12-18 CN CN2009801575427A patent/CN102333533A/zh active Pending
- 2009-12-18 CA CA2748319A patent/CA2748319A1/en not_active Abandoned
- 2009-12-18 EA EA201101012A patent/EA019110B1/ru not_active IP Right Cessation
- 2009-12-18 PE PE2011001296A patent/PE20120424A1/es not_active Application Discontinuation
- 2009-12-18 WO PCT/EP2009/067494 patent/WO2010076238A1/en not_active Ceased
- 2009-12-18 JP JP2011544017A patent/JP2012514020A/ja active Pending
- 2009-12-18 EP EP09799340A patent/EP2381943A1/en not_active Withdrawn
- 2009-12-18 SG SG2011047339A patent/SG172415A1/en unknown
- 2009-12-18 BR BRPI0924067A patent/BRPI0924067A2/pt not_active IP Right Cessation
- 2009-12-18 MA MA34018A patent/MA32968B1/fr unknown
- 2009-12-18 NZ NZ593949A patent/NZ593949A/xx not_active IP Right Cessation
- 2009-12-18 MX MX2011007064A patent/MX2011007064A/es active IP Right Grant
- 2009-12-18 KR KR1020117017495A patent/KR20110120878A/ko not_active Withdrawn
- 2009-12-18 US US13/142,333 patent/US8389530B2/en not_active Expired - Fee Related
-
2011
- 2011-06-23 IL IL213742A patent/IL213742A0/en unknown
- 2011-06-27 TN TN2011000319A patent/TN2011000319A1/fr unknown
- 2011-06-27 CR CR20110368A patent/CR20110368A/es not_active Application Discontinuation
- 2011-06-28 ZA ZA2011/04777A patent/ZA201104777B/en unknown
- 2011-06-29 DO DO2011000209A patent/DOP2011000209A/es unknown
- 2011-06-29 NI NI201100134A patent/NI201100134A/es unknown
- 2011-06-29 CO CO11081323A patent/CO6390105A2/es not_active Application Discontinuation
- 2011-07-14 EC EC2011011204A patent/ECSP11011204A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012514020A5 (https=) | ||
| JP2009535362A5 (https=) | ||
| CA2748319A1 (en) | Substituted quinazoline compounds of general formula (i) and uses thereof for treating disorders relating to tyrosine kinase dysregulation | |
| JP2009534398A5 (https=) | ||
| JP2009534471A5 (https=) | ||
| ES2552977T3 (es) | Amino-quinolinas como inhibidores de quinasa | |
| JP2012525332A5 (https=) | ||
| TW434227B (en) | Novel N-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immune modulating effect | |
| ME01462B (me) | Vinilindazolilna jedinjenja" | |
| RU2485115C2 (ru) | Производные пиримидина в качестве ингибиторов alk-5 | |
| ES2324710T3 (es) | Indolinonas sustituidas con heterociclos y su uso como inhibidores de receptores de tirosina quinasa. | |
| JP2008513500A5 (https=) | ||
| CA3172387A1 (en) | Indazole based compounds and associated methods of use | |
| JP2009535356A5 (https=) | ||
| JP2006500348A5 (https=) | ||
| JP2007509985A5 (https=) | ||
| JP2005509624A5 (https=) | ||
| JP2010521451A5 (https=) | ||
| ATE509935T1 (de) | Mischungen aus mono-carboxylfunktionalisierten dialkylphosphinsäuren, ein verfahren zu ihrer herstellung und ihre verwendung | |
| JP2005539000A (ja) | Ａｌｋ５阻害剤としての２−フェニルピリジン−４−イル誘導体 | |
| JP2005529954A5 (https=) | ||
| CA2628233A1 (en) | 5-lipoxygenase-activating protein (flap) inhibitors | |
| JP2006528940A5 (https=) | ||
| JP2006521359A5 (https=) | ||
| RU2013153540A (ru) | Аминопиридинсодержащие ингибиторы тирозинкиназы селезенки (syk) |